Internalization of anti-Hu IgG is not Fc gamma receptor mediated
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Patients with paraneoplastic subacute sensory neuronopathy or encephalomyelitis associated with small cell lung cancer cells (SCLC) frequently harbor anti-Hu antibodies (also called antineuronal nuclear antibodies type 1) in serum and CSF. [1] These antibodies react with a family of nuclear proteins, with apparent molecular mass ranging from 35 to 45 kD, expressed in neurons and SCLC cells. [2] Anti-Hu antibodies are one example of ANA associated with autoimmune disease. ANA occur in a variety of autoimmune disorders, most classically systemic lupus erythematosus. The ability of these antibodies to interact with nuclear antigens in living cells has been questioned and the relevance of the antibodies to disease production doubted. However, several groups have demonstrated that autoantibodies can penetrate living cells. [3]
Anti-Hu IgG penetrates viable Hu-positive SCLC cells and localizes in the nucleus. [4] How this IgG internalizes into the cell and translocates to the nucleus is unknown. Immunocytochemistry, immunoprecipitation, and flow cytometry show no Hu antigen on the cell surface (Lieberman and Hormigo, unpublished data; Posner, personal communication). Alternatively, internalization may be mediated by receptors that recognize the Fc portion of immunoglobulin molecules, the Fc gamma receptors (Fc gamma Rs). Fc gamma Rs comprise a family of molecules within the immunoglobulin superfamily. There are three main classes: Fc gamma RI, Fc gamma RII, and Fc gamma RIII. [5] For example, the internalization of …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.